Company Filing History:
Years Active: 2022
Title: Innovations in Cardiac Treatment by Douglas Boatman
Introduction
Douglas Boatman is an accomplished inventor based in Petaluma, CA (US). He has made significant contributions to the field of cardiac health through his innovative research and development of compounds aimed at treating cardiac arrhythmias and heart failure. His work focuses on modulating the activity of calcium ion channels, which play a crucial role in heart function.
Latest Patents
Douglas Boatman holds a patent for "Compounds for treatment of cardiac arrhythmias and heart failure." This patent discloses compounds and methods for modulating the activity of calcium ion channels, including Ca-induced calcium release channels and conformationally coupled calcium release channels such as ryanodine receptors. Some of the compounds have a structure according to formula I, or a stereoisomer, tautomer, hydrate, solvate, prodrug, or pharmaceutically acceptable salt thereof. He has 1 patent to his name.
Career Highlights
Douglas Boatman is currently associated with Elex Biotech, Inc., where he continues to advance his research in cardiac treatments. His work has the potential to significantly impact the lives of individuals suffering from heart conditions.
Collaborations
He collaborates with talented individuals such as Josephrajan Thainashmuthu and Martha Sibrian-Vazquez, contributing to a dynamic research environment focused on innovative solutions in biotechnology.
Conclusion
Douglas Boatman's contributions to cardiac health through his innovative compounds and research are noteworthy. His work exemplifies the importance of innovation in the medical field, particularly in addressing critical health issues such as cardiac arrhythmias and heart failure.